120 related articles for article (PubMed ID: 17974960)
1. Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
Zhang L; Wali A; Ramana CV; Rishi AK
Cancer Res; 2007 Nov; 67(21):10198-206. PubMed ID: 17974960
[TBL] [Abstract][Full Text] [Related]
2. Okadaic acid-mediated induction of the c-fos gene in estrogen receptor-negative human breast carcinoma cells utilized, in part, posttranscriptional mechanisms involving adenosine-uridine-rich elements.
Farhana L; Boyanapalli M; Tschang SH; Sun RJ; Hsu CK; Zhang YX; Fontana JA; Rishi AK
Cell Growth Differ; 2000 Oct; 11(10):541-50. PubMed ID: 11063127
[TBL] [Abstract][Full Text] [Related]
3. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
4. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
5. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells.
Ao L; Liu JY; Gao LH; Liu SX; Yang MS; Huang MH; Cao J
Toxicol In Vitro; 2008 Feb; 22(1):116-27. PubMed ID: 17935941
[TBL] [Abstract][Full Text] [Related]
7. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
10. A nucleus-localization-deficient mutant serves as a dominant-negative inhibitor of gut-enriched Krüppel-like factor function.
Shie JL; Tseng CC
Biochem Biophys Res Commun; 2001 Apr; 283(1):205-8. PubMed ID: 11322789
[TBL] [Abstract][Full Text] [Related]
11. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells.
Wassmann S; Wassmann K; Jung A; Velten M; Knuefermann P; Petoumenos V; Becher U; Werner C; Mueller C; Nickenig G
J Mol Cell Cardiol; 2007 Sep; 43(3):301-7. PubMed ID: 17659301
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis.
Wang F; Zhu Y; Huang Y; McAvoy S; Johnson WB; Cheung TH; Chung TK; Lo KW; Yim SF; Yu MM; Ngan HY; Wong YF; Smith DI
Oncogene; 2005 Jun; 24(24):3875-85. PubMed ID: 15735666
[TBL] [Abstract][Full Text] [Related]
14. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis.
Lee WH; Liu FH; Lin JY; Huang SY; Lin H; Liao WJ; Huang HM
J Cell Biochem; 2009 Apr; 106(5):929-36. PubMed ID: 19180571
[TBL] [Abstract][Full Text] [Related]
15. Analysis of c-myc expression in a human hepatoma cell line.
Huber BE; Thorgeirsson SS
Cancer Res; 1987 Jul; 47(13):3414-20. PubMed ID: 3034414
[TBL] [Abstract][Full Text] [Related]
16. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
17. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
18. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor.
Mao Z; Song S; Zhu Y; Yi X; Zhang H; Shang Y; Tong T
Oncogene; 2003 Jul; 22(28):4434-43. PubMed ID: 12853980
[TBL] [Abstract][Full Text] [Related]
20. The c-myc promoter: still MysterY and challenge.
Wierstra I; Alves J
Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
